drugset / Trial / NCT00117325
Study Of Adults And Adolescents With Vasomotor Rhinitis
RandomizedParallel-groupTreatment
Summary
The primary objective of this study is to compare the efficacy and safety of GW685698X 100mcg once daily (QD) aqueous nasal spray with vehicle placebo nasal spray in adult and adolescent subjects (12 years of age and older) with vasomotor rhinitis (VMR).
Timeline
- Start
- 2005-07-11
- Primary completion
- 2006-02-09
- Completion
- 2006-02-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fluticasone Furoate | Other / unclassified | 100 ug | Intranasal |